These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38384303)

  • 41. Metabolomic and transcriptomic signatures of influenza vaccine response in healthy young and older adults.
    Chou CH; Mohanty S; Kang HA; Kong L; Avila-Pacheco J; Joshi SR; Ueda I; Devine L; Raddassi K; Pierce K; Jeanfavre S; Bullock K; Meng H; Clish C; Santori FR; Shaw AC; Xavier RJ
    Aging Cell; 2022 Sep; 21(9):e13682. PubMed ID: 35996998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity Is Associated with an Impaired Baseline Repertoire of Anti-Influenza Virus Antibodies.
    Abd Alhadi M; Friedman LM; Karlsson EA; Cohen-Lavi L; Burkovitz A; Schultz-Cherry S; Noah TL; Weir SS; Shulman LM; Beck MA; Hertz T
    Microbiol Spectr; 2023 Jun; 11(3):e0001023. PubMed ID: 37098954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
    Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.
    Patel N; Penkert RR; Jones BG; Sealy RE; Surman SL; Sun Y; Tang L; DeBeauchamp J; Webb A; Richardson J; Heine R; Dallas RH; Ross AC; Webby R; Hurwitz JL
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31575021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults.
    Kennedy RB; Simon WL; Gibson MJ; Goergen KM; Grill DE; Oberg AL; Poland GA
    Immunology; 2016 Jul; 148(3):266-75. PubMed ID: 27188667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct Functional Humoral Immune Responses Are Induced after Live Attenuated and Inactivated Seasonal Influenza Vaccination.
    Tong X; Deng Y; Cizmeci D; Fontana L; Carlock MA; Hanley HB; McNamara RP; Lingwood D; Ross TM; Alter G
    J Immunol; 2024 Jan; 212(1):24-34. PubMed ID: 37975667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals.
    Xia Y; Mi F; Du G; Qin S
    Hum Vaccin Immunother; 2021 Jan; 17(1):124-132. PubMed ID: 32412824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults.
    Meade P; Kuan G; Strohmeier S; Maier HE; Amanat F; Balmaseda A; Ito K; Kirkpatrick E; Javier A; Gresh L; Nachbagauer R; Gordon A; Krammer F
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
    Powell TJ; Peng Y; Berthoud TK; Blais ME; Lillie PJ; Hill AV; Rowland-Jones SL; McMichael AJ; Gilbert SC; Dong T
    PLoS One; 2013; 8(5):e62778. PubMed ID: 23658773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination.
    Hayashi T; Momota M; Kuroda E; Kusakabe T; Kobari S; Makisaka K; Ohno Y; Suzuki Y; Nakagawa F; Lee MSJ; Coban C; Onodera R; Higashi T; Motoyama K; Ishii KJ; Arima H
    Front Immunol; 2018; 9():2619. PubMed ID: 30515151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets.
    Hay JA; Laurie K; White M; Riley S
    PLoS Comput Biol; 2019 Aug; 15(8):e1007294. PubMed ID: 31425503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Mayuramart O; Poomipak W; Rattanaburi S; Khongnomnan K; Anuntakarun S; Saengchoowong S; Chavalit T; Chantaravisoot N; Payungporn S
    PeerJ; 2022; 10():e13989. PubMed ID: 36164603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine.
    Williams KV; Moehling Geffel K; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Susick M; Zimmerman RK
    Vaccine; 2023 Jan; 41(3):862-869. PubMed ID: 36543682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.
    Bethell D; Saunders D; Jongkaewwattana A; Kramyu J; Thitithayanont A; Wiboon-ut S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Uthaimongkol N; Garcia JM; Timmermans AE; Peiris M; Thomas S; Engering A; Jarman RG; Mongkolsirichaikul D; Mason C; Khemnu N; Tyner SD; Fukuda MM; Walsh DS; Pichyangkul S
    PLoS One; 2013; 8(3):e59674. PubMed ID: 23555741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.